MobileCaps: A Lightweight Model for Screening and Severity Analysis of COVID-19 Chest X-Ray Images
This work addresses the urgent need for accurate and efficient COVID-19 screening tools in healthcare systems, though it is incremental as it builds on existing architectures.
The authors tackled the problem of screening COVID-19 cases and assessing severity from chest X-ray images by developing MobileCaps, a lightweight model combining MobileNetV2 and Capsule Networks, which achieved recalls of 91.60-94.60% and an R² of 70.51 for severity.
The world is going through a challenging phase due to the disastrous effect caused by the COVID-19 pandemic on the healthcare system and the economy. The rate of spreading, post-COVID-19 symptoms, and the occurrence of new strands of COVID-19 have put the healthcare systems in disruption across the globe. Due to this, the task of accurately screening COVID-19 cases has become of utmost priority. Since the virus infects the respiratory system, Chest X-Ray is an imaging modality that is adopted extensively for the initial screening. We have performed a comprehensive study that uses CXR images to identify COVID-19 cases and realized the necessity of having a more generalizable model. We utilize MobileNetV2 architecture as the feature extractor and integrate it into Capsule Networks to construct a fully automated and lightweight model termed as MobileCaps. MobileCaps is trained and evaluated on the publicly available dataset with the model ensembling and Bayesian optimization strategies to efficiently classify CXR images of patients with COVID-19 from non-COVID-19 pneumonia and healthy cases. The proposed model is further evaluated on two additional RT-PCR confirmed datasets to demonstrate the generalizability. We also introduce MobileCaps-S and leverage it for performing severity assessment of CXR images of COVID-19 based on the Radiographic Assessment of Lung Edema (RALE) scoring technique. Our classification model achieved an overall recall of 91.60, 94.60, 92.20, and a precision of 98.50, 88.21, 92.62 for COVID-19, non-COVID-19 pneumonia, and healthy cases, respectively. Further, the severity assessment model attained an R$^2$ coefficient of 70.51. Owing to the fact that the proposed models have fewer trainable parameters than the state-of-the-art models reported in the literature, we believe our models will go a long way in aiding healthcare systems in the battle against the pandemic.